What is Chardan Capital’s Forecast for RCKT FY2025 Earnings?
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) – Analysts at Chardan Capital lifted their FY2025 earnings per share (EPS) estimates for Rocket Pharmaceuticals in a research report issued on Wednesday, May 28th. Chardan Capital analyst Y. Livshits now anticipates that the biotechnology company will post earnings of ($2.24) per share for the year, up from […]
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) – Analysts at Chardan Capital lifted their FY2025 earnings per share (EPS) estimates for Rocket Pharmaceuticals in a research report issued on Wednesday, May 28th. Chardan Capital analyst Y. Livshits now anticipates that the biotechnology company will post earnings of ($2.24) per share for the year, up from […]
